Not Signed In - Ranbaxy Receives USFDA Approval for Zidovudine Tablets
Thu, 14 Jul 2005 03:00 AM EST
... Ranbaxy Laboratories Limited (RLL) announced today that it has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets 300 mg... click link for more info. ...
Related Topics
- Lamivudine and Zidovudine
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Abacavir, Zidovudine and Lamivudine
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Thiabendazole Tablets
- Haloperidol Tablets
- Lamivudine
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Desmopressin Tablets
- Nystatin Tablets
- Zidovudine Capsule
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Tarceva
- Gatifloxacin tablets
email this page
print this page
bookmark this page
feedback on this page
